Sands Capital Ventures, LLC Spruce Biosciences, Inc. Transaction History
Sands Capital Ventures, LLC
- $264 Million
- Q4 2024
A detailed history of Sands Capital Ventures, LLC transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Sands Capital Ventures, LLC holds 715,817 shares of SPRB stock, worth $300,643. This represents 0.11% of its overall portfolio holdings.
Number of Shares
715,817
Previous 787,007
9.05%
Holding current value
$300,643
Previous $369,000
20.6%
% of portfolio
0.11%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding SPRB
# of Institutions
32Shares Held
15.9MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.94MShares$1.23 Million20.39% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$1.22 Million1.19% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$1.1 Million0.04% of portfolio
-
Abingworth LLP London, X01.79MShares$752,8570.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.05MShares$439,2470.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $9.9M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...